Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75,482,273
-
Total 13F shares
-
262,671
-
Share change
-
+59,624
-
Total reported value
-
$407,000
-
Price per share
-
$1.55
-
Number of holders
-
9
-
Value change
-
+$89,335
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q4 2018
As of 31 Dec 2018,
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
262,671 shares.
The largest 9 holders included
SPHERA FUNDS MANAGEMENT LTD., MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, UBS Group AG, US BANCORP \DE\, and LADENBURG THALMANN FINANCIAL SERVICES INC..
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.